POET Technologies Inc. (POET) is a Toronto-based fabless semiconductor company developing Optical Interposer platform technology — a novel approach to integrating electronic and photonic devices — primarily targeting AI data center optical networking applications. Shares dropped roughly 17% in premarket trading on May 15, 2026, from a prior session close of approximately $25.40, touching an intraday low near $13.90 before recovering sharply. The immediate trigger was the release of Q1 2026 earnings, in which the company reported a loss wider than analysts expected on a per-share basis, even as revenue surpassed forecasts. The earnings-driven move reflects investor sensitivity to profitability metrics in a stock that has already experienced extreme volatility in recent weeks.
The core driver of today's selloff is POET's Q1 2026 financial results, released before the opening bell on May 15, 2026. The company posted a GAAP EPS of -$0.08, missing the consensus estimate of -$0.05 by $0.03 — a shortfall of approximately 60% relative to expectations. For a pre-revenue-stage company whose valuation is almost entirely speculative and sentiment-driven, an EPS miss of this magnitude can sharply reset investor expectations, particularly after a sustained price rally.
On the revenue side, POET delivered $0.5 million in quarterly revenue, representing a 194.1% year-over-year increase and beating the consensus revenue estimate by $0.25 million. While the revenue beat demonstrates early commercial traction for the company's optical engine technology, the absolute dollar figure remains small relative to the company's market capitalization, and the wider net loss underscored that POET remains firmly in investment mode with significant operating expenses ahead of it.
Partially tempering the earnings-driven selloff, POET also announced on May 15 a technology partnership with Lumilens to advance wafer-level photonic integration for next-generation AI optical networks. An analyst video review from May 14 noted that a deal tied to the Lumilens relationship involved an initial order valued at approximately $50 million, with the broader partnership potentially expanding over several years depending on development and production milestones. Warrants granted to Lumilens as part of the agreement could introduce additional dilution risk down the line, a consideration that sophisticated investors are beginning to price in.
The partnership reinforces POET's commercial narrative around AI optical connectivity, but the market's reaction suggests that near-term execution — specifically on the path to sustained, recurring revenue — matters more to investors at current valuation levels than further strategic announcements.
Today's decline must be understood in the context of POET's extraordinary recent price history. In late April 2026, the stock cratered nearly 50% after MRVL (Marvell Technology) canceled all purchase orders previously placed through its Celestial AI acquisition, following a dispute over POET's public disclosure of order details. The stock then staged a strong recovery of approximately 50% in the first week of May, driven by unconfirmed speculation linking POET to potential interest from QCOM (Qualcomm) and ongoing enthusiasm around its photonic platform. That volatile backdrop means the stock entered today's session elevated and vulnerable to any negative surprise in the earnings print.
Trading volume in POET is running well above its average daily levels, consistent with prior high-volatility sessions around major news events. The stock swung from a premarket-driven low of $13.90 to an intraday high of $25.68 on May 15 — a range of nearly 85% within a single session — reflecting the speculative, retail-driven nature of POET's current shareholder base. Broader semiconductor and photonics peers did not exhibit similar volatility, suggesting the price action is idiosyncratic to POET rather than a sector-wide move. The high short interest in the stock — near record levels in recent weeks — is amplifying both the downside moves and the intraday recovery bounces.
Navigating a stock like POET — with its sharp intraday swings and sentiment-driven volatility — requires disciplined, rules-based approaches that remove emotion from execution. Tickeron's Trending AI Robots page showcases a curated selection of the platform's top-performing AI trading bots under current market conditions. Tickeron runs hundreds of AI-powered bots covering thousands of tickers, but only those demonstrating the strongest live performance metrics are featured in this section. Bots vary in strategy (momentum, mean reversion, breakout), timeframe, risk tolerance, and the specific symbols they trade. Traders looking for a data-driven edge in today's volatile markets may find it worthwhile to explore what the Trending AI Robots section currently has to offer.
The formal earnings call and any updated management guidance on customer order pipelines, manufacturing ramp timelines, and revenue visibility for the second half of 2026 will be closely watched by investors in the sessions ahead. Engineering samples from the Lumilens partnership are expected in late 2026, with production timing tied to customer deployment schedules in 2027, meaning near-term revenue contributions from this deal remain limited. Analyst coverage of POET remains sparse, and the absence of formal sell-side consensus leaves the stock highly susceptible to retail sentiment and social media-driven narratives.
Key risks include continued dilution from future capital raises — POET has already completed several large registered direct offerings in 2025 and early 2026 — ongoing net losses, the absence of significant recurring revenue, and the potential for further customer relationship disruptions similar to the Marvell episode. The warrants associated with the Lumilens deal could also add to share count over time.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
POET may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 37 cases where POET's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.
Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where POET advanced for three days, in of 236 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 110 cases where POET Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The 10-day RSI Indicator for POET moved out of overbought territory on May 15, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Momentum Indicator moved below the 0 level on June 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on POET as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
The Moving Average Convergence Divergence Histogram (MACD) for POET turned negative on May 26, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where POET declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. POET’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. POET’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 63, placing this stock worse than average.
The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.223) is normal, around the industry mean (17.469). P/E Ratio (0.000) is within average values for comparable stocks, (288.211). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.792). POET has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.015). POET's P/S Ratio (833.333) is very high in comparison to the industry average of (57.028).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry Semiconductors